These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 15466851)

  • 21. Extending treatment for HCV infection to HIV-HCV coinfected individuals with psychiatric illness and drug dependence.
    Taylor LE; Schwartzapfel B; Allen S; Jacobs G; Mitty J
    Clin Infect Dis; 2003 Jun; 36(11):1501-2; author reply 1502-3. PubMed ID: 12766851
    [No Abstract]   [Full Text] [Related]  

  • 22. Interferon-based hepatitis C treatment in patients with pre-existing severe mental illness and substance use disorders.
    Freedman K; Nathanson J
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):363-76. PubMed ID: 19344248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C Treatment: Clinical Issues for Psychiatrists in the Post-Interferon Era.
    Chasser Y; Kim AY; Freudenreich O
    Psychosomatics; 2017; 58(1):1-10. PubMed ID: 27871760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: the National Drug Abuse Treatment Clinical Trials Network.
    Brown LS; Kritz SA; Goldsmith RJ; Bini EJ; Rotrosen J; Baker S; Robinson J; McAuliffe P
    J Subst Abuse Treat; 2006 Jun; 30(4):315-21. PubMed ID: 16716846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?
    Schaefer M; Heinz A; Backmund M
    Addiction; 2004 Sep; 99(9):1167-75. PubMed ID: 15317637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users.
    Edlin BR; Kresina TF; Raymond DB; Carden MR; Gourevitch MN; Rich JD; Cheever LW; Cargill VA
    Clin Infect Dis; 2005 Apr; 40 Suppl 5(Suppl 5):S276-85. PubMed ID: 15768335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Barriers to treatment of hepatitis C in HIV/HCV-coinfected adults with alcohol problems.
    Nunes D; Saitz R; Libman H; Cheng DM; Vidaver J; Samet JH
    Alcohol Clin Exp Res; 2006 Sep; 30(9):1520-6. PubMed ID: 16930214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrating care for hepatitis C virus (HCV) and primary care for HIV for injection drug users coinfected with HIV and HCV.
    Kresina TF; Bruce RD; Cargill VA; Cheever LW
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S83-8. PubMed ID: 16265621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of human immunodeficiency virus, hepatitis B, and hepatitis C among homeless persons with co-occurring severe mental illness and substance use disorders.
    Klinkenberg WD; Caslyn RJ; Morse GA; Yonker RD; McCudden S; Ketema F; Constantine NT
    Compr Psychiatry; 2003; 44(4):293-302. PubMed ID: 12923707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in access to care among injection drug users infected either with HIV and hepatitis C or hepatitis C alone.
    Braitstein P; Li K; Kerr T; Montaner JS; Hogg RS; Wood E
    AIDS Care; 2006 Oct; 18(7):690-3. PubMed ID: 16971276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C, mental health and equity of access to antiviral therapy: a systematic narrative review.
    Hepworth J; Bain T; van Driel M
    Int J Equity Health; 2013 Nov; 12():92. PubMed ID: 24245959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectrum of disease in U.S. veteran patients with hepatitis C.
    Nguyen HA; Miller AI; Dieperink E; Willenbring ML; Tetrick LL; Durfee JM; Ewing SL; Ho SB
    Am J Gastroenterol; 2002 Jul; 97(7):1813-20. PubMed ID: 12135041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-world effectiveness and safety of direct-acting antivirals in hepatitis C virus patients with mental disorders.
    Dybowska D; Zarębska-Michaluk D; Rzymski P; Berak H; Lorenc B; Sitko M; Dybowski M; Mazur W; Tudrujek-Zdunek M; Janocha-Litwin J; Janczewska E; Klapaczyński J; Parfieniuk-Kowerda A; Piekarska A; Sobala-Szczygieł B; Dobrowolska K; Pawłowska M; Flisiak R
    World J Gastroenterol; 2023 Jul; 29(25):4085-4098. PubMed ID: 37476581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy.
    Chander G; Himelhoch S; Moore RD
    Drugs; 2006; 66(6):769-89. PubMed ID: 16706551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon-alpha can be used successfully in patients with hepatitis C virus-positive chronic hepatitis who have a psychiatric illness.
    Van Thiel DH; Friedlander L; Molloy PJ; Fagiuoli S; Kania RJ; Caraceni P
    Eur J Gastroenterol Hepatol; 1995 Feb; 7(2):165-8. PubMed ID: 7712309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
    Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP;
    Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: challenges and opportunities.
    Litwin AH; Soloway I; Gourevitch MN
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S339-45. PubMed ID: 15768345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychiatric disorders, HIV infection and HIV/hepatitis co-infection in the correctional setting.
    Baillargeon JG; Paar DP; Wu H; Giordano TP; Murray O; Raimer BG; Avery EN; Diamond PM; Pulvino JS
    AIDS Care; 2008 Jan; 20(1):124-9. PubMed ID: 18278623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying Barriers to the Treatment of Chronic Hepatitis C Infection.
    Al-Khazraji A; Patel I; Saleh M; Ashraf A; Lieber J; Malik R
    Dig Dis; 2020; 38(1):46-52. PubMed ID: 31422405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clients' perceptions of barriers and facilitators to implementing hepatitis C virus care in homeless shelters.
    Masson CL; Fokuo JK; Anderson A; Powell J; Zevin B; Bush D; Khalili M
    BMC Infect Dis; 2020 May; 20(1):386. PubMed ID: 32471376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.